MedPath

Characterization of Beta Cell Failure

Not Applicable
Withdrawn
Conditions
Diabetes
Metabolic Syndrome
Interventions
Registration Number
NCT00869102
Lead Sponsor
University Hospital Tuebingen
Brief Summary

The purpose of this study is to characterise beta cell function in subjects who despite taking part in a diabetes prevention program (life style intervention with diet and exercise) exhibit impaired glucose tolerance and beta cell dysfunction.

Detailed Description

We have identified a subgroup of individuals with a good compliance to lifestyle intervention to prevent diabetes who lose body weight and increase insulin sensitivity, however they remain impaired glucose tolerant. These individuals show a deterioration in insulin secretory function.

We will identify a highly selected group of subjects with prediabetes that displays a large defect in insulin secretory function.We will study 50 individuals who display these characteristics and 50 subjects who do not display these characteristics. Their insulin secretion capacity in response to different secretagogues (glucose, GLP-1, arginine) will be studied. We expect to detect new pathophysiologic aspects that lead to beta cell failure particularly in this group.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Impaired glucose tolerance
  • BMI 16-40 kg/m²
Exclusion Criteria
  • chronic disease
  • anemia
  • therapy with insulin or cortisone

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
GLP-1GLP-1-
Primary Outcome Measures
NameTimeMethod
Insulin secretion1 day
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Tübingen

🇩🇪

Tübingen, Germany

© Copyright 2025. All Rights Reserved by MedPath